Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jie Tu, Tianbao Zhu, Qingwen Wang, Wanzhen Yang, Yahui Huang, Defeng Xu, Na Liu & Chunquan Sheng. (2023) Discovery of a new chemical scaffold for the treatment of superbug Candida auris infections. Emerging Microbes & Infections 12:1.
Read now
Read now
Arunaloke Chakrabarti & Shreya Singh. (2020) Multidrug-resistant Candida auris: an epidemiological review. Expert Review of Anti-infective Therapy 18:6, pages 551-562.
Read now
Read now
Muluneh Ademe & Friehiwot Girma. (2020) Candida auris: From Multidrug Resistance to Pan-Resistant Strains. Infection and Drug Resistance 13, pages 1287-1294.
Read now
Read now
Siang Fei Yeoh, Tae Jin Lee, Ka Lip Chew, Stephen Lin, Dennis Yeo & Sajita Setia. (2018) Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. Infection and Drug Resistance 11, pages 805-819.
Read now
Read now
Matthew W. McCarthy & Thomas J. Walsh. (2018) Candidemia in the cancer patient: diagnosis, treatment, and future directions. Expert Review of Anti-infective Therapy 16:11, pages 849-854.
Read now
Read now
Matthew William McCarthy & Thomas J. Walsh. (2017) Containment strategies to address the expanding threat of multidrug-resistant Candida auris. Expert Review of Anti-infective Therapy 15:12, pages 1095-1099.
Read now
Read now
Articles from other publishers (50)
Sapna Kalra, Sunita Tanwar & Vinay Kumar Bari. (2024) Insights into the role of sphingolipids in antifungal drug resistance. Fungal Biology Reviews 47, pages 100342.
Crossref
Crossref
Sada Raza, Mateusz Wdowiak, Mateusz Grotek, Witold Adamkiewicz, Kostiantyn Nikiforow, Pumza Mente & Jan Paczesny. (2023) Enhancing the antimicrobial activity of silver nanoparticles against ESKAPE bacteria and emerging fungal pathogens by using tea extracts. Nanoscale Advances 5:21, pages 5786-5798.
Crossref
Crossref
Puneet Jangir, Sapna Kalra, Sunita Tanwar & Vinay Kumar Bari. (2023)
Azole resistance in
Candida auris
: mechanisms and combinatorial therapy
. APMIS 131:8, pages 442-462.
Crossref
Crossref
Kashish MadaanVinay Kumar Bari. (2023) Emerging Role of Sphingolipids in Amphotericin B Drug Resistance. Microbial Drug Resistance 29:8, pages 319-332.
Crossref
Crossref
Sergio A. Alanís-Ríos, Gloria M. González, Angel Andrade, Miguel A. Becerril-García, Alexandro Bonifaz, Efrén R. Robledo-Leal, Alexandra M. Montoya & Rogelio de J. Treviño-Rangel. (2022) Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris. Brazilian Journal of Microbiology 53:4, pages 2003-2008.
Crossref
Crossref
Jie Tu, Na Liu, Yahui Huang, Wanzhen Yang & Chunquan Sheng. (2022) Small molecules for combating multidrug-resistant superbug Candida auris infections. Acta Pharmaceutica Sinica B 12:11, pages 4056-4074.
Crossref
Crossref
Rogelio de J. Treviño-Rangel, Gloria M. González, Alexandra M. Montoya, Olga C. Rojas, Mariana Elizondo-Zertuche & Neri A. Álvarez-Villalobos. (2022) Recent Antifungal Pipeline Developments against Candida auris: A Systematic Review. Journal of Fungi 8:11, pages 1144.
Crossref
Crossref
Mohmmad Younus Wani, Aijaz Ahmad, Faisal Mohammed Aqlan & Abdullah Saad Al-Bogami. (2022) Modulation of key antioxidant enzymes and cell cycle arrest as a possible antifungal mode of action of cinnamaldehyde based azole derivative. Bioorganic & Medicinal Chemistry Letters 73, pages 128922.
Crossref
Crossref
Maqsood Ahmad Malik, Maha G. Batterjee, Majid Rasool Kamli, Khalid Ahmed Alzahrani, Ekram Y. Danish & Arshid Nabi. (2022) Polyphenol-Capped Biogenic Synthesis of Noble Metallic Silver Nanoparticles for Antifungal Activity against Candida auris. Journal of Fungi 8:6, pages 639.
Crossref
Crossref
Hasti Kamali Sarvestani, Alireza Ramandi, Muhammad Ibrahim Getso, Taraneh Razavyoon, Javad Javidnia, Miaad Banay Golrizi, Ali-Akbar Saboor-Yaraghi & Saham Ansari. (2022) Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology. Brazilian Journal of Microbiology 53:2, pages 689-707.
Crossref
Crossref
Alex Mas-Sandoval, Chenyu Jin, Marco Fracassetti & Matteo Fumagalli. (2023) ngsJulia: population genetic analysis of next-generation DNA sequencing data with Julia language. F1000Research 11, pages 126.
Crossref
Crossref
Alex Mas-Sandoval, Chenyu Jin, Marco Fracassetti & Matteo Fumagalli. (2022) ngsJulia: population genetic analysis of next-generation DNA sequencing data with Julia language. F1000Research 11, pages 126.
Crossref
Crossref
Weifeng Hao, Yaxian Wang, Yue Xi, Zhe Yang, Heyu Zhang & Xuejun Ge. (2022) Activity of chlorhexidine acetate in combination with fluconazole against suspensions and biofilms of Candida auris. Journal of Infection and Chemotherapy 28:1, pages 29-34.
Crossref
Crossref
Manzoor Ahmad Mir, Hafsa Qadri, Shariqa Aisha & Abdul Haseeb Shah. 2022. Human Pathogenic Microbes. Human Pathogenic Microbes
207
232
.
Frederic Pereira & Blandine Rammaert. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
315
329
.
María Guadalupe Frías-De-León, Eduardo García-Salazar, María del Rocío Reyes-Montes, Esperanza Duarte-Escalante & Gustavo Acosta-Altamirano. 2022. The Impact of Climate Change on Fungal Diseases. The Impact of Climate Change on Fungal Diseases
161
179
.
Ronnie G. Willaert, Yeseren Kayacan & Bart Devreese. (2021) The Flo Adhesin Family. Pathogens 10:11, pages 1397.
Crossref
Crossref
Ahmed Gamal, Lisa Long, Janet Herrada, Jalal Aram, Thomas S. McCormick & Mahmoud A. Ghannoum. (2021) Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis. Antimicrobial Agents and Chemotherapy 65:9.
Crossref
Crossref
Hafsa Qadri, Munazah Fazal Qureshi, Manzoor Ahmad Mir & Abdul Haseeb Shah. (2021) Glucose - The X factor for the survival of human fungal pathogens and disease progression in the host. Microbiological Research 247, pages 126725.
Crossref
Crossref
Shan Hu, Feilong Zhu, Weiwei Jiang, Yuehua Wang, Yongqiang Quan, Guoming Zhang, Feng Gu & Ying Yang. (2021) Retrospective Analysis of the Clinical Characteristics of Candida auris Infection Worldwide From 2009 to 2020. Frontiers in Microbiology 12.
Crossref
Crossref
Lucia Černáková, Maryam Roudbary, Susana Brás, Silva Tafaj & Célia F. Rodrigues. (2021) Candida auris: A Quick Review on Identification, Current Treatments, and Challenges. International Journal of Molecular Sciences 22:9, pages 4470.
Crossref
Crossref
Arunaloke Chakrabarti & Prashant Sood. (2021) On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points. Journal of Medical Microbiology 70:3.
Crossref
Crossref
Irene Jurado-Martín, Cristina Marcos-Arias, Esther Tamayo, Andrea Guridi, Piet W. J. de Groot, Guillermo Quindós & Elena Eraso. (2020) Candida duobushaemulonii: An Old But Unreported Pathogen. Journal of Fungi 6:4, pages 374.
Crossref
Crossref
Mykola Rybalkin, Leonid Strelnikov, Oksana Strilets, Olha Kaliuzhnaia & Sergiy Kutsenko. (2020) Chemical Analysis and the Study of Quality Indicators of the Immunobiological Drug for Preventing and Treating Candidal Infections. Chemistry & Chemical Technology 14:4, pages 455-462.
Crossref
Crossref
Jiangqing Huang, Shengcen Zhang, Qirong Xiao, Yingping Cao & Bin Li. (2020) YouTube™ as a source of information for Candida auris infection: a systematic review. BMC Public Health 20:1.
Crossref
Crossref
Virginia Basso, Dat Q. Tran, André J. Ouellette & Michael E. Selsted. (2020) Host Defense Peptides as Templates for Antifungal Drug Development. Journal of Fungi 6:4, pages 241.
Crossref
Crossref
Robert C. Walchak, Seanne P. Buckwalter, Nicole M. Zinsmaster, Katrina M. Henn, Katelyn M. Johnson, Jolene M. Koelsch, Senait A. Herring, Lory K. Steinmetz, Katelyn A. Reed, Jean E. Barth, Jenna M. Rasmusson, Jill L. Fischer, Paula Snippes Vagnone, Priya Sampathkumar & Nancy L. Wengenack. (2020) Candida auris Direct Detection from Surveillance Swabs, Blood, and Urine Using a Laboratory-Developed PCR Method. Journal of Fungi 6:4, pages 224.
Crossref
Crossref
Balaji Pathakumari, Guanzhao Liang & Weida Liu. (2020) Immune defence to invasive fungal infections: A comprehensive review. Biomedicine & Pharmacotherapy 130, pages 110550.
Crossref
Crossref
Juan C. Gómez-Velásquez, Natalia Loaiza-Díaz, Gilma Norela Hernández, Nelson Lima & Ana C. Mesa-Arango. (2020) Development and Validation of an In-House Library for Filamentous Fungi Identification by MALDI-TOF MS in a Clinical Laboratory in Medellin (Colombia). Microorganisms 8:9, pages 1362.
Crossref
Crossref
Jason Tan, Joyce Tay, James Hedrick & Yi Yan Yang. (2020) Synthetic macromolecules as therapeutics that overcome resistance in cancer and microbial infection. Biomaterials 252, pages 120078.
Crossref
Crossref
Tina Z. Wang, Kindra N. White, Jillian Villani Scarr, Matthew S. Simon & David P. Calfee. (2020) Preparing your healthcare facility for the new fungus among us: An infection preventionist's guide to Candida auris. American Journal of Infection Control 48:7, pages 825-827.
Crossref
Crossref
Marie Helleberg, Karin Meinike Jørgensen, Rasmus Krøger Hare, Raluca Datcu, Anuradha Chowdhary & Maiken Cavling Arendrup. (2020)
Rezafungin
In Vitro
Activity against Contemporary Nordic Clinical
Candida
Isolates and
Candida auris
Determined by the EUCAST Reference Method
. Antimicrobial Agents and Chemotherapy 64:4.
Crossref
Crossref
Yee-Chun Chen. 2020. Clinical Practice of Medical Mycology in Asia. Clinical Practice of Medical Mycology in Asia
243
255
.
Chong W. Ong, Sharon C.‐A. Chen, Julia E. Clark, Catriona L. Halliday, Sarah E. Kidd, Deborah J. Marriott, Caroline L. Marshall, Arthur J. Morris, C. Orla Morrissey, Rita Roy, Monica A. Slavin, Andrew J. Stewardson, Leon J. Worth & Christopher H. Heath. (2019)
Diagnosis, management and prevention of
Candida auris
in hospitals: position statement of the Australasian Society for Infectious Diseases
. Internal Medicine Journal 49:10, pages 1229-1243.
Crossref
Crossref
S. Iguchi, Y. Itakura, A. Yoshida, K. Kamada, R. Mizushima, Y. Arai, Y. Uzawa & K. Kikuchi. (2019) Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains. Journal of Infection and Chemotherapy 25:10, pages 743-749.
Crossref
Crossref
R K Jackler & T A Jan. (2019) The future of otology. The Journal of Laryngology & Otology 133:09, pages 747-758.
Crossref
Crossref
S. Ghazi, R. Rafei, M. Osman, D. El Safadi, H. Mallat, N. Papon, F. Dabboussi, J.-P. Bouchara & M. Hamze. (2019) The epidemiology of Candida species in the Middle East and North Africa. Journal de Mycologie Médicale 29:3, pages 245-252.
Crossref
Crossref
Shabir A. Lone & Aijaz Ahmad. (2019)
Candida auris
—the growing menace to global health
. Mycoses 62:8, pages 620-637.
Crossref
Crossref
Justyna Cieślik & Marta Wróblewska. (2019) MALDI TOF MS – new possibilities in routine microbiological diagnostics. Diagnostyka Laboratoryjna 54:2, pages 99-104.
Crossref
Crossref
S. Mahmoudi, S. Agha Kuchak Afshari, S. Aghaei Gharehbolagh, H. Mirhendi & K. Makimura. (2019) Methods for identification of Candida auris, the yeast of global public health concern: A review. Journal de Mycologie Médicale 29:2, pages 174-179.
Crossref
Crossref
Haroldo Cesar de Oliveira, Maria Candida Monteiro, Suélen Andreia Rossi, Javier Pemán, Alba Ruiz-Gaitán, Maria José Soares Mendes-Giannini, Emilia Mellado & Oscar Zaragoza. (2019) Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
G. Tetz, M. Collins, D. Vikina & V. Tetz. (2019)
In Vitro
Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of
Candida glabrata
,
Candida auris
,
Cryptococcus neoformans
, and
Pneumocystis
spp
. Antimicrobial Agents and Chemotherapy 63:4.
Crossref
Crossref
Beata Sulik-Tyszka, Urszula Nawrot, Olga Saran & Marta Wróblewska. (2018) Candida auris – susceptibility to antifungals and treatment recommendations. Diagnostyka Laboratoryjna 55:1, pages 49-54.
Crossref
Crossref
Andrea Cortegiani, Giovanni Misseri, Teresa Fasciana, Anna Giammanco, Antonino Giarratano & Anuradha Chowdhary. (2018) Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. Journal of Intensive Care 6:1.
Crossref
Crossref
Janaina de Cássia Orlandi Sardi, Diego Romário Silva, Maria José Soares Mendes-Giannini & Pedro Luiz Rosalen. (2018) Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options. Microbial Pathogenesis 125, pages 116-121.
Crossref
Crossref
Virginia Basso, Angie Garcia, Dat Q. Tran, Justin B. Schaal, Patti Tran, Diana Ngole, Younus Aqeel, Prasad Tongaonkar, André J. Ouellette & Michael E. Selsted. (2018) Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species. Antimicrobial Agents and Chemotherapy 62:6.
Crossref
Crossref
Thomas J. Walsh, Randall T. Hayden & Davise H. Larone. 2018. Larone’s Medically Important Fungi. Larone’s Medically Important Fungi
469
494
.
Gloria Hoi Wan Tso, Jose Antonio Reales-Calderon & Norman Pavelka. (2018) The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future. Frontiers in Immunology 9.
Crossref
Crossref
Marta Wróblewska & Beata Sulik-Tyszka. (2017) Candida auris – epidemiology and laboratory diagnostics of infections. Diagnostyka Laboratoryjna 53:4, pages 235-240.
Crossref
Crossref
Glauber R de S Araújo, Wanderley de Souza & Susana Frases. (2017) The hidden pathogenic potential of environmental fungi. Future Microbiology 12:16, pages 1533-1540.
Crossref
Crossref